title: Association of postoperative furosemide use with a reduced blood transfusion rate in sagittal craniosynostosis surgery.
abstract: OBJECT A major challenge in sagittal craniosynostosis surgery is the high transfusion rate (50%-100%) related to blood loss in small pediatric patients. Several approaches have been proposed to prevent packed red blood cell (PRBC) transfusion, including endoscopic surgery, erythropoietin ortranexamic acid administration, and preoperative hemodilution. The authors hypothesized that a significant proportion of postoperative anemia observed in pediatric patients is actually dilutional. Consequently, since 2005, at CHU Sainte-Justine, furosemide has been administered to correct the volemic status and prevent PRBC transfusion. The purpose of this study was to evaluate the impact of postoperative furosemide administration on PRBC transfusion rates. METHODS This was a retrospective study of 96 consecutive patients with sagittal synostosis who underwent surgery at CHU Sainte-Justine between January 2000 and May 2012. The mean age at surgery was 4.9 ± 1.5 months (range 2.8-8.7 months). Patients who had surgery before 2005 constituted the control group. Those who had surgery in 2005 or 2006 were considered part of an implementation phase because furosemide administration was not routine. Patients who had surgery after 2006 were part of the experimental (or furosemide) group. Transfusion rates among the 3 groups were compared. The impact of furosemide administration on transfusion requirement was also measured while accounting for other variables of interest in a multiple logistic regression model. RESULTS The total transfusion rate was significantly reduced in the furosemide group compared with the control group (31.3% vs 62.5%, respectively; p = 0.009), mirroring the decrease in the postoperative transfusion rate between the groups (18.3% vs 50.0%, respectively; p = 0.003). The postoperative transfusion threshold remained similar throughout the study (mean hemoglobin 56.0 g/dl vs 60.9 g/dl for control and furosemide groups, respectively; p = 0.085). The proportion of nontransfused patients with recorded hemoglobin below 70 g/dl did not differ between the control and furosemide groups (41.7% vs 28.6%, respectively; p = 0.489). Surgical procedure, preoperative hemoglobin level, estimated blood loss, and furosemide administration significantly affected the risk of receiving a postoperative PRBC transfusion. When these variables were analyzed in a multiple logistic regression model, furosemide administration remained strongly associated with a reduced risk of being exposed to a blood transfusion (OR 0.196, p = 0.005). There were no complications related to furosemide administration. CONCLUSIONS A significant part of the postoperative anemia observed in patients who underwent sagittal craniosynostosis surgery was due to hypervolemic hemodilution. Correction of the volemic status with furosemide administration significantly reduces postoperative PRBC transfusion requirements in these patients.
authors.affiliation: Section of Neurosurgery and.
authors.forename: Adil
authors.initials: A
authors.lastname: Harroud
authors.affiliation: Section of Neurosurgery and.
authors.forename: Alexander G
authors.initials: AG
authors.lastname: Weil
authors.affiliation: Department of Pediatrics, CHU Sainte-Justine, Montréal, Québec, Canada.
authors.forename: Jean
authors.initials: J
authors.lastname: Turgeon
authors.affiliation: Section of Neurosurgery and.
authors.forename: Claude
authors.initials: C
authors.lastname: Mercier
authors.affiliation: Section of Neurosurgery and.
authors.forename: Louis
authors.initials: L
authors.lastname: Crevier
mesh_terms: D016063:Blood Loss, Surgical / Q000706:statistics & numerical data; D003398:Craniosynostoses / Q000601:surgery*; D003399:Craniotomy / Q000009:adverse effects / Q000706:statistics & numerical data*; D004232:Diuretics / Q000008:administration & dosage / Q000494:pharmacology*; D017707:Erythrocyte Transfusion / Q000706:statistics & numerical data*; D005260:Female; D005665:Furosemide / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007223:Infant; D008297:Male; D017063:Outcome Assessment, Health Care / Q000706:statistics & numerical data*; D011183:Postoperative Complications / Q000628:therapy*
chemical_list: D004232:Diuretics; D005665:Furosemide
keywords: CBL = calculated blood loss; EBL = estimated blood loss; EBV = estimated blood volume; PRBC = packed red blood cell; blood; craniofacial; craniosynostosis; craniotomy; furosemide; hemoglobin; sagittal suture; sagittal synostosis surgery; scaphocephaly; transfusion